Chavant Capital Acquisition Corp. |
Director |
Class A Common Stock |
541K |
$5.41M |
$10.00 |
Dec 21, 2023 |
Indirect |
Bionik Laboratories Corp. |
Director |
Common Stock |
1.11M |
$666K |
$0.60 |
Jun 13, 2023 |
Shares held through Star SCI |
Chavant Capital Acquisition Corp. |
Director |
Class A Common Stock |
27.8K |
$278K |
$10.00 |
Dec 21, 2023 |
Direct |
Bionik Laboratories Corp. |
Director |
Common Stock |
95.1K |
$57.1K |
$0.60 |
Jun 13, 2023 |
Direct |
Bionik Laboratories Corp. |
Director |
Common Stock |
10.7K |
$6.42K |
$0.60 |
Jun 13, 2023 |
Shares held through 4A Consulting and Engineering |
Chavant Capital Acquisition Corp. |
Director |
Make-Whole Shares (right to acquire) |
145K |
|
|
Dec 21, 2023 |
Indirect |
Bionik Laboratories Corp. |
Director |
Convertible Promissory Note |
1 |
|
|
Jun 13, 2023 |
Through Star SCI |
Bionik Laboratories Corp. |
Director |
Stock Option (right to buy) |
0 |
|
|
Jul 15, 2021 |
Direct |